Dermatofibrosarcoma protuberans (DFSP) – advances in diagnostics and therapy

Journal Title: OncoReview - Year 2011, Vol 1, Issue 2

Abstract

Dermatofibrosarcoma protuberans is a rare soft tissue sarcoma with a superficial growth. It has an estimated incidence of 4 cases per one million persons per year. DFSP is preferentially located on the trunk. It can appear at any age, although it is much more frequent in individuals aged between 20 and 50 years. Its growth is slow and indolent and it can last for years. With time it can accelerate and characteristic protuberant masses appear, from which the disease took its name. Distant metastases are rare, more common in the fibrosarcomatous type (FS-DFSP), with incidence of about 10% of all DFSP, and it is characterized by more aggressive behavior and poorer prognosis. In more than 95% of DFSP cases a characteristic genetic disturbance was demonstrated, which is responsible for its carcinogenesis. Translocation between chromosomes 17 and 22 results in excessive activation of PDGFRβ and in increasing of the tumor cells proliferation. Excision with wide margins is the primary treatment option for DFSP. Though improvement of surgical modalities, including microsurgery, local recurrence rates are still high. Outcomes are better with the use of postoperative radiotherapy. Using in therapy kinase inhibitor imatinib was a breakthrough in treatment of patients with locally advanced or metastatic disease. Its activity is based on inhibition of PDGFRβ activation, which is responsible for development of this tumor type.

Authors and Affiliations

Hanna Koseła, Piotr Rutkowski

Keywords

Related Articles

Primary cutaneous B-cell lymphoma located on the face and hard palate

[b]Introduction[/b]: Primary cutaneous B-cell lymphomas represent primary cutaneous lymphomas. The World Health Organization-European Organization for Research and Treatment of Cancer defines primary cutaneous B-cell lim...

Knowledge about prevention, risk factors and treatment in women with diagnosed breast cancer. Whether the disease affects their healthy behaviour?

Objective. The assessment of knowledge about prevention and risk factors of women with diagnosed breast cancer.Material and methods. The study involved 100 women aged from 28 to 82 years (median 56.2 years) who were trea...

PPARs and their role in cancer

Peroxisome proliferator activated receptors are members of a very common group of steroid nuclear receptors. The aim of the study was to present actual knowledge regarding the role of PPAR in cancerogenesis. Three types...

The cardiac safety during treatment with sunitinib and sorafenib, multikinase angiogenesis inhibitors

Cardiotoxicity of multikinase angiogenesis inhibitors, sunitinib and sorafenib, is most often myocardial systolic dysfunction or arterial and venous thromboembolic events. Essential risk factor seems to be iatrogenic art...

Download PDF file
  • EP ID EP53098
  • DOI -
  • Views 257
  • Downloads 0

How To Cite

Hanna Koseła, Piotr Rutkowski (2011). Dermatofibrosarcoma protuberans (DFSP) – advances in diagnostics and therapy. OncoReview, 1(2), -. https://europub.co.uk/articles/-A-53098